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MARCO variants are associated with phagocytosis,
pulmonary tuberculosis susceptibility and Beijing lineage
NTT Thuong1,2, TTB Tram1,2, TD Dinh1,2, PVK Thai3, D Heemskerk1,2, ND Bang3, TTH Chau4, DG Russell5, GE Thwaites1,2, TR Hawn6,
M Caws7 and SJ Dunstan8
Macrophage receptor with collagenous structure (MARCO) has an important role in the phagocytosis of Mycobacterium tuberculosis
(M. tuberculosis). We hypothesized that MARCO polymorphisms are associated with phagocytosis, tuberculosis (TB) disease
susceptibility and presentation, and infecting lineage. We used a human cellular model to examine how MARCO genotype mediates
the immune response; a case–control study to investigate tuberculosis host genetic susceptibility; and a host–pathogen genetic
analysis to study host–pathogen interactions. Two MARCO heterozygous (AG) genotypes (single-nucleotide polymorphisms rs2278589
and rs6751745) were associated with impaired phagocytosis of M. tuberculosis trehalose 6,6'-dimycolate-cord factor and β-glucan-
coated beads in macrophages. The heterozygous genotypes of rs2278589 and rs6751745 were also associated with increased risk of
pulmonary TB (PTB; rs2278589, P=0.001, odds ratio (OR)= 1.6; rs6751745, P=0.009, OR=1.4), and with severe chest X-ray abnormalities
(P=0.007, OR=1.6). These two genotypes were also associated with the Beijing lineage (rs2278589, P=0.001, OR=1.7; rs6751745,
P=0.01, OR=1.5). Together, these results suggest that MARCO polymorphisms may regulate phagocytosis of M. tuberculosis and
susceptibility and severity of PTB. They also suggest MARCO genotype and Beijing strains may interact to increase the risk of PTB.
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INTRODUCTION
Although tuberculosis (TB) can be cured, it is still one of the most
devastating diseases, and globally causes active TB in 9.6 million
and kills 1.5 million people annually.1 Variation in the host and
pathogen are involved in disease susceptibility and determine
disease development and outcome. Studies suggest that poly-
morphisms in host immunity genes inﬂuence susceptibility to TB,2,3
especially in genes encoding Toll-like receptors, C-type lectin and
scavenger receptors, which are involved in recognizing, binding
and phagocytosing Mycobacterium tuberculosis (M. tuberculosis).
Scavenger receptors are cell surface receptors, which bind a
variety of ligands, and have an important function in clearance of
many foreign microorganisms. Class A and class B scavenger
receptors are involved in the cytokine response to mycobacterial
lipoarabinomannans4 and lipopeptides.5 Macrophage receptor
with collagenous structure (MARCO) is a member of the class A
scavenger receptor family. MARCO, on the cell surface of
macrophages, binds bacteria to facilitate phagocytosis and
activates immune responses.6–8 As such, MARCO-deﬁcient mice
have a reduced ability to clear bacteria in pneumonia.7,9 Class A
scavenger receptors and MARCO participate in phagocytosis of
mycobacterial species, including Mycobacterium leprae,10 Myco-
bacterium bovis Bacille Calmette–Guérin,11 Mycobacterium
marinum6 and M. tuberculosis.12,13 More speciﬁcally, it has been
demonstrated that M. tuberculosis is captured by MARCO in vivo
via its cell wall cord factor (trehalose 6,6'-dimycolate or TDM),
which increases pro-inﬂammatory cytokine response through the
interaction with Toll-like receptors and CD14.14
The genetic diversity of M. tuberculosis is another factor that
contributes to the clinical consequences of TB.15–17 The emer-
gence of Beijing strains, which account for ~ 50% of strains in East
Asia and 13% of strains worldwide,18 may contribute to disease
susceptibility, drug resistance and treatment outcome. There is a
possibility of human-mycobacterial co-evolution based on the
genetic interactions of genes in the host and pathogen.18,19 This
would help to explain the interactions between host and
pathogen factors in the development of TB.
Altogether, due to the role of phagocytosis and the potential
function of MARCO in the immune response against M. tuberculosis,
we hypothesized that (i) phagocytic activity is associated with
developing different clinical phenotypes of TB, such as latent,
pulmonary or extra-pulmonary TB; (ii) polymorphisms in MARCO
regulate macrophage phagocytic activity; (iii) polymorphisms in
MARCO, which contribute to the impairment of macrophage
phagocytic activity, are associated with susceptibility to tuberculosis
and inﬂuence clinical presentations and treatment failure; (iv) host and
pathogen genotypes combined inﬂuence tuberculosis susceptibility.
RESULTS
Phagocytosis and TB clinical phenotypes
We examined phagocytosis in human monocyte-derived macro-
phages (MDMs) by bead-based internalization assays. Alexa
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594-beads coated with immunoglobulin-G (IgG), TDM or β-glucan
were added to MDMs and the percentage of macrophages with or
without beads was measured using ﬂow cytometry to assess
phagocytic ability. Phagocytosis was assessed in macrophages
isolated from patients with latent (N= 56), pulmonary (N= 52) or
meningeal TB (N= 55). No association was observed between
phagocytic activity and different clinical forms of TB (Figure 1).
There was a wide range of phagocytic activities, with up to 50% of
beads coated with M. tuberculosis TDM in macrophages from latent,
pulmonary and meningeal TB (Figure 1). To investigate how MARCO
inﬂuences the heterogeneity of phagocytic activity, we next
examined the association of MARCO variants and phagocytosis.
Association of MARCO SNPs with macrophage phagocytosis,
mRNA expression and cytokines in response to M. tuberculosis
MARCO is a phagocytic receptor on macrophages which binds
bacteria and facilitates phagocytosis to control and clear
pathogens.6,8 TDM from M. tuberculosis is a ligand of MARCO,
whereas β-glucan is not known to be a MARCO ligand. Scavenger
receptors on human monocytes have been found to bind to
β-glucan,20 and MARCO (on CpG-ODN-pretreated macrophages)
has been found to participate in the uptake of zymosan (which is
derived from β-glucan);21 therefore β-glucan was used in this
study to address the question of whether it might be a ligand for
MARCO and to explore possible interaction between MARCO,
tuberculosis and β-glucan.
We genotyped 12 MARCO haplotype-tagging single-nucleotide
polymorphisms (SNPs) from 41 healthy subjects and performed
phagocytosis assays. The genotypes of two SNPs, rs2278589 and
rs6751745, were associated with phagocytosis of either TDM or
β-glucan beads, but were not associated with phagocytosis of IgG
beads (Figures 2a and b). The remaining 10 SNPs in MARCO were
not associated with phagocytosis of any beads (Supplementary
Figure S1). Furthermore, the results show the heterozygous
genotypes of both SNPs were associated with reduced phagocy-
tosis of TDM and β-glucan beads (rs2278589, P= 0.04 and 0.03;
rs6751745, P= 0.01 and 0.007; Figures 2a and b).
We also examined the association between MARCO SNPs
rs2278589 and rs6751745 and messenger RNA (mRNA) expression
or cytokines in Peripheral blood mononuclear cells (PBMCs) from 31
healthy subjects. MARCO mRNA levels were up-regulated approxi-
mately twofold in PBMCs stimulated with lipopolysaccharide (LPS) or
M. tuberculosis whole-cell lysate compared with unstimulated cells
(Figure 3a). The genotypes of rs2278589 and rs6751745 were
marginally associated with MARCO mRNA expression in cells
stimulated with M. tuberculosis (Figure 3b; analysis of variance,
P=0.068 and 0.039, respectively). For the heterozygous model, the
AG genotype of these two SNPs was not signiﬁcantly associated
with reduced levels of MARCO mRNA in PBMCs stimulated with
M. tuberculosis. For cytokine production, PBMCs were activated and
produced pro-inﬂammatory cytokines TNF-α and IL-1β in response
to both TDM and M. tuberculosis lysate. The anti-inﬂammatory
cytokine IL-10 was induced by M. tuberculosis lysate stimulation, but
not TDM (Figure 3c). In TDM or M. tuberculosis lysate stimulated cells,
there was no association between the two SNP genotypes and
TNF-α, IL-1β and IL-10 levels (Figures 3d and e for rs2278589, and
Figures 3f and g for rs6751745).
Collectively, these data showed that the AG genotype of
rs2278589 and rs6751745 in MARCO was not associated with
MARCO mRNA expression or cytokine concentrations in PBMCs,
but it was associated with reduced phagocytosis activated via
TDM and β-glucan in macrophages.
MARCO polymorphisms are associated with susceptibility to
pulmonary TB, but not with TB meningitis
We used a case–control study to determine whether MARCO
polymorphisms SNPs rs2278589 and rs6751745 are associated with
susceptibility to TB, as macrophages with the heterozygote
genotypes of these SNPs displayed reduced phagocytosis of
M. tuberculosis ligands (Figure 2). Therefore we applied the
heterozygote advantage model to analyze the relationship between
MARCO SNPs and clinical TB, both pulmonary and meningeal. The
heterozygote genotypes of rs2278589 and rs6751745 are asso-
ciated with susceptibility to pulmonary tuberculosis (PTB;
rs2278589; P=0.001, odds ratio (OR)= 1.6 and rs6751745;
P=0.009, OR=1.4; Table 1) and Supplementary Figure S2 shows
that the two SNPs are in high linkage disequilibrium (LD) (D' = 1,
r2 = 0.88) in our Vietnamese Kinh control population. Associations
between these two SNPs and PTB remained signiﬁcant after
Bonferroni correction (P-values ×2; Table 1).
Figure 1. Phagocytic ability of macrophages from individuals with
different TB phenotypes. Monocyte-derived macrophages from
patients at day 7 were treated with Alexa 547-beads coated with
either immunoglobulin-G (IgG), trehalose 6,6'-dimycolate (TDM) or
β-glucan. Phagocytic ability was determined by the percentage of
macrophages with beads in three TB phenotypes (55 TB meningitis,
52 pulmonary TB and 56 latent TB). Bars in plots represent median
values. Comparisons across three groups of TB forms or genotypes
were performed by using one-way analysis of variance. On these
comparisons, P-values 40.05.
Figure 2. Phagocytic ability of macrophages from healthy subjects.
Macrophage phagocytosis of beads was assessed according to
MARCO SNP genotypes in healthy subjects; (a) rs2278589 (18 GG, 18
AG, 5 AA) and (b) rs6751745 (19 GG, 18 AG, 4 AA). Bars in plots
represent median values. Comparisons across three groups of TB
forms or genotypes were performed by using one-way analysis of
variance, or two groups by using Mann–Whitney U-test.
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Interestingly, the genotype frequencies of these two SNPs were
different between PTB and tuberculous meningitis (TBM) under
the heterozygote advantage model ((rs2278589; PTB 0.55, TBM
0.46; P= 0.005, OR= 1.4) (rs6751745; PTB 0.50, TBM 0.40; P= 0.003,
OR= 1.5)). However the genotype frequencies of rs2278589 and
rs6751745 in TBM patients were not different compared to the
control groups using the genotypic model (P40.05).
To thoroughly examine the association between MARCO SNPs
and TB a further 10 SNPs, within and upstream of the MARCO
gene, were analyzed. Apart from the two associated SNPs
described above, rs6748401 (1.5 kb upstream) was associated
with PTB in a genotypic comparison (P= 0.039; Table 2), and none
of others were associated with susceptibility to TB.
Collectively, two SNPs in the MARCO gene were associated with
PTB, but not with TBM. The heterozygote genotypes of rs2278589
and rs6751745, which were associated with reduced phagocytic
activity, were also associated with susceptibility to PTB.
MARCO polymorphisms are associated with CXR presentation
To investigate whether MARCO polymorphisms inﬂuence
clinical presentation or disease outcome, we examined the
relationship between the two associated SNPs (rs2278589 and
rs6751745), pre-treatment chest X-ray (CXR) abnormalities
and 8-month treatment outcomes. Patients enrolled in this
study were sputum smear-positive for PTB before treatment.
Pre-treatment CXR showed 427/429 (99.5%) were abnormal with
evidence of nodules (139, 32.4%), inﬁltrates (407, 94.9%),
consolidation (40, 9.3%), cavities (139, 32.4%) and miliary
disease (0, 0%).
SNPs rs2278589 and rs6751745 were associated with severity of
CXR abnormality. SNP rs2278589 was associated with intermediate
and severe CXR abnormality in the heterozygote model (P= 0.008
intermediate; P= 0.007 severe, OR= 1.6; Table 3). SNP rs6751745
was associated with severe CXR abnormality in the heterozygote
model (P= 0.007, OR= 1.6; Table 3).
Figure 3. MARCO polymorphisms and variation in mRNA expression or cytokine production from healthy subjects. (a) mRNA was isolated
from monocytes stimulated with Media, LPS at 100 ng ml− 1 or M. tuberculosis whole-cell lysate at 5 μg ml− 1. MARCO mRNA expression was
measured and normalizes to glyceraldehyde-3-phosphate dehydrogenase. (b) Association of MARCO mRNA expression from cells stimulated
with M. tuberculosis whole-cell lysate was analyzed with SNPs in MARCO: rs2278589 (4 AA, 12 AG, 15 GG), P= 0.068 and rs6751745 (3 AA, 13 AG,
15 GG), P= 0.039. (c) Cytokines were measured from monocytes stimulated with media, TDM at 100 μg ml− 1 or M. tuberculosis whole-cell lysate
at 25 μg ml− 1. Cytokines from cells stimulated with TDM (d) or M. tuberculosis whole-cell lysate (e) were analyzed with SNP rs2278589 (4 AA, 12
AG, 15 GG). Cytokines from cells stimulated with TDM (f) or M. tuberculosis whole-cell lysate (g) were analyzed with SNP rs6751745 (3 AA, 13
AG, 15 GG). Data were collected from duplicate samples. Bars in plots represent median values. Comparisons across three genotypes were
performed by using one-way analysis of variance.
Table 1. MARCO SNPs rs2278589 and rs6751745 are associated with pulmonary TB
SNP rs2278589 rs6751745
Control genotype (11, 12, 22) (N, %) 194 (0.45) 190 (0.44) 48 (0.11) 210 (0.48) 181 (0.42) 43 (0.10)
PTB genotype (11, 12, 22) (N, %) 165 (0.37) 245 (0.55) 35 (0.08) 194 (0.43) 225 (0.50) 27 (0.06)
Genotypic (P, P*) 0.004 0.008 0.011 0.022
Dominant (P, P*, OR (95% CI)) 0.101 0.202 1.5 (0.9-2.3) 0.035 0.070 1.7 (1.0–2.8)
Recessive (P, P*, OR (95% CI)) 0.018 0.036 0.7 (0.5–0.9) 0.146 0.292 0.8 (0.6–1.1)
Heterozygous (P, P*, OR (95% CI)) 0.001 0.002 1.6 (1.2–2.0) 0.009 0.018 1.4 (1.1–1.8)
Abbreviations: OR (95% CI), odds ratio (95% conﬁdence interval); SNP, single-nucleotide polymorphism. 1: majority allele; 2: minority allele; Dominant is the
comparison of 22 vs (11+12). P= P-value. P*= corrected P-value, Bonferroni correction by two SNPs (P-values × 2). Bold entries indicate P-values o0.05.
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There was no association between rs2278589 and rs6751745
genotype and poor treatment outcome (29/429, 6%), which was
deﬁned by death, or failure to convert to sputum smear negativity,
however this may be due to the lack of events in this data set and
consequent lack of power.
MARCO polymorphisms are associated with Beijing lineage
Our previous studies reported associations between lineages of
M. tuberculosis, particularly the modern Beijing lineage, and TB
clinical phenotypes.15,17 Given a worldwide emergence of the
M. tuberculosis Beijing strains,18 we hypothesized that variation in
the scavenger receptor MARCO, which binds to Mycobacterium
and enables phagocytosis by macrophages, might be preferen-
tially associated with a speciﬁc lineage. Therefore, we next
examined whether the rs2278589 and rs6751745 genotypes are
associated with infection caused by a particular bacterial lineage
and whether this relationship inﬂuences disease phenotype.
The genotypic frequencies of rs2278589 and rs6751745 in all
PTB patients (N= 445) and in those patients where the lineage of
the infecting M. tuberculosis isolate was determined (N= 370),
were compared with controls (Table 4). There was no signiﬁcant
association between the two SNPs and infection with either Indo-
Oceanic or Euro-American lineage, or when combined as non-
Beijing lineages. However, we found a signiﬁcant association
between these SNPs and infection with Beijing isolates in a
genotypic comparison (rs2278589, P= 0.005; rs6751745, P= 0.033;
Table 4), and in a heterozygous model (rs2278589, P= 0.001,
OR= 1.7; rs6751745, P= 0.012, OR= 1.5; Table 4).
Table 2. Summary of genotyped SNPs in MARCO
rs ID Location Cases Controls Genotypic
PTB/TBM 11/12/22 11/12/22 HWE-P P-values
rs7573346 PTB 131/233/84 122/213/105 0.524 0.175
4.9 Kb upstream TBM 127/216/101 0.913
rs6748401 PTB 108/245/90 120/215/100 0.845 0.039
1.5 Kb upstream TBM 115/223/109 0.788
rs1318645 PTB 109/246/92 119/215/100 0.879 0.057
3 bp upstream TBM 115/223/109 0.815
rs4491733 PTB 104/240/102 114/228/93 0.290 0.593
intron 1 TBM 120/222/101 0.782
rs12998782 PTB 228/184/34 243/160/31 0.510 0.345
intron 1 TBM 239/168/33 0.883
rs17009726 PTB 331/110/8 340/94/6 0.863 0.456
intron 1 TBM 342/99/5 0.911
rs2278589 PTB 165/245/35 194/190/48 0.885 0.004
intron 3 TBM 194/203/47 0.871
rs1371562 PTB 289/141/15 284/138/15 0.724 0.998
intron 6 TBM 286/140/15 0.998
rs6761637 PTB 323/114/8 335/89/9 0.289 0.202
exon 10 TBM 333/101/6 0.519
rs6751745 PTB 194/225/27 210/181/43 0.663 0.011
intron 13 TBM 223/178/39 0.752
rs17796260 PTB 293/139/13 283/135/18 0.708 0.622
intron 13 TBM 292/136/14 0.739
rs3765035 PTB 145/251/49 152/220/60 0.164 0.210
intron 15 TBM 183/199/60 0.149
Abbreviations: HWE, Hardy–Weinberg equilibrium; P, P-value; PTB, pulmonary tuberculosis; TBM, tuberculous meningitis. 1: majority allele; 2: minority allele.
Bold values indicate the SNPs that have genotypic P-values o0.05.
Table 3. MARCO SNPs rs2278589 and rs6751745 are associated with level of CXR abnormality in PTB patients
Abnormality level Genotype Genotypic Heterozygous
GG AG AA P-values P-values OR (95% CI)
rs2278589
Controls 194 (0.45) 190 (0.44) 48 (0.11)
Mild 26 (0.38) 39 (0.57) 4 (0.06) 0.112 0.052 1.7 (1.0–2.7)
Intermediate 67 (0.37) 101 (0.56) 13 (0.07) 0.022 0.008 1.6 (1.1–2.3)
Severe 60 (0.35) 96 (0.56) 15 (0.09) 0.026 0.007 1.6 (1.1–2.3)
rs6751745
Controls 210 (0.48) 181 (0.42) 43 (0.10)
Mild 31 (0.44) 35 (0.50) 4 (0.06) 0.314 0.193 1.4 (0.8–2.3)
Intermediate 82 (0.45) 90 (0.50) 9 (0.05) 0.055 0.068 1.4 (1.0–2.0)
Severe 68 (0.40) 92 (0.54) 11 (0.06) 0.026 0.007 1.6 (1.1–2.3)
Bold entries indicate P-values o0.05.
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DISCUSSION
The primary ﬁnding of our study was that MARCO genotypes were
associated with a reduction of phagocytosis of beads coated with
pathogen-derived ligands, TDM from M. tuberculosis. These
genotypes were also associated with increased susceptibility to
PTB and severe chest radiography abnormality. Our results
suggest that these polymorphisms may regulate phagocytosis of
M. tuberculosis, and impairment of phagocytic ability could
increase susceptibility to, and severity of, PTB. The MARCO
genotypes were preferentially associated with Beijing rather than
Indo-Oceanic or Euro-American lineages, which implies MARCO
genotype may increase susceptibility to tuberculosis particularly of
the Beijing lineage.
MARCO has a key role in bacterial phagocytosis and
clearance.6,7,9 Recognition of TDM by MARCO, in conjunction with
TLR2/CD4, activates transcriptional expression of immunity
genes22 and cytokine production.14 However, no studies have
yet shown the inﬂuence of MARCO genetic variation on the
antimicrobial activity of macrophages such as phagocytosis or
immune response. In this study, we found that MARCO SNPs
rs2278589 and rs6751745 were not associated with gene
expression and cytokine production in PBMCs but were associated
with reduced phagocytosis of beads coated with pathogen-
derived ligands, TDM or β-glucan in macrophages. We found that
MARCO polymorphisms were not associated with cytokine
production. In murine studies, MARCO-deﬁcient macrophages
were associated with a reduction of TNFα, IL-6 and IL-1β cytokine
production in macrophages from MARCO knockout mice. The
difference in study design could account for the differences seen
in cytokine production between these two studies. We used
human PBMCs, whereas in Bowdish et al.14 murine macrophages
were used. In the macrophages from knockout mice, MARCO was
absent, potentially having a major impact. In our study, MARCO
was still produced, albeit a variant of MARCO with an unknown
and potentially smaller impact. Another reason for the difference
may be the limited numbers of samples in our study once
stratiﬁed by genotype.
MARCO is involved in phagocytosis of bacteria, a step in
pathogenesis that may be important in the development of PTB in
the early phase of infection. The heterozygous genotypes of two
MARCO SNPs were associated with reduced macrophage phago-
cytic function. The impairment of phagocytosis at the beginning
of infection reduces the number of macrophages infected with
M. tuberculosis, which then limits microbial killing and antigen
presentation to lymphocytes.23,24 The consequence of this could
be the inadequate induction of innate and adaptive immune
responses against M. tuberculosis, potentially increasing suscept-
ibility to active disease. Deﬁcient responses could also lead to
increased microbial replication, which could manifest as severe
abnormalities on CXR, such as was observed in TB patients
carrying the heterozygous genotypes. Together, our data suggest
that TB susceptibility and disease severity in patients with the
MARCO AG genotype may be due to impairment of M. tuberculosis
phagocytosis.
Our results show that variation in human MARCO is associated
with susceptibility to PTB in the Vietnamese Kinh population. The
associated intronic SNPs rs6748401 and rs2278589 are part of a
wide haplotype block, suggesting they are markers in high LD
with the unknown causative SNP(s). Two MARCO SNPs
(rs17009726 or rs4491733) were previously associated with TB
susceptibility in the Han Chinese Beijing and Gambian
populations;25,26 however, we did not observe any association
with these SNPs in our TB population. Conversely, the associated
SNPs (rs6748401 and rs2278589) described in this study were not
associated in the Gambian population and were not genotyped in
the Chinese population. The discrepancy in our results may be due
to different population LD structure. The frequencies of the
associated SNPs found in the three studies were very different
based on the 1000 Genomes Project (http://www.ncbi.nlm.nih.
gov/projects/SNP; rs17009726 minor allele frequency in African
0.0008, Ad Mixed American 0.0014, European 0.0060, East Asian
0.1210 and South Asian 0.1483 super populations) and overall
linkage (D' plots) across the MARCO SNPs in three populations are
visually different (Supplementary Figure S2; Bowdish et al.25 and
Ma et al.26). LD in the Vietnamese Kinh population across this gene
region contains larger haplotype blocks with more SNPs
compared with both the Han Chinese (HCB) and Gambian
populations. The differing population structures in this gene
region may account for the inability to replicate individual SNP
associations, however the accumulated evidence across these
populations suggests that MARCO variation contributes to PTB
susceptibility.
The remarkable emergence of Beijing lineage worldwide,
including Vietnam, supports the hypothesis that the variation in
the scavenger receptor MARCO, which binds Mycobacterium and
promotes macrophage internalization, might support the emer-
gence of the Beijing lineages. Our data show associations of both
MARCO variants and M. tuberculosis lineage with TB susceptibility
suggesting potential for host–pathogen co-evolution, as reported
previously with TLR2, NRAMP1 and EREG.15,27,28 Our associated
Table 4. MARCO SNPs rs2278589 and rs6751745 are associated with the Beijing strain
Group Genotype Genotypic Heterozygous
GG AG AA P-values P-values OR (95%CI)
rs2278589
Controls 194 (0.45) 190 (0.44) 48 (0.11)
PTB 165 (0.37) 245 (0.55) 35 (0.08) 0.004 0.001 1.6 (1.2–2.0)
All isolates 135 (0.36) 205 (0.55) 30 (0.08) 0.005 0.001 1.6 (1.2–2.1)
Non-Beijing 61 (0.42) 77 (0.53) 8 (0.05) 0.060 0.066 1.4 (1.0–2.1)
East Asian/Beijing 74 (0.33) 128 (0.57) 22 (0.10) 0.005 0.001 1.7 (1.2–2.3)
rs6751745
Controls 210 (0.48) 181 (0.42) 43 (0.10)
PTB 194 (0.43) 225 (0.50) 27 (0.06) 0.011 0.009 1.4 (1.1–1.9)
All isolates 161 (0.47) 187 (0.48) 23 (0.05) 0.021 0.014 1.4 (1.1–1.9)
Non-Beijing 68 (0.47) 70 (0.48) 8 (0.05) 0.174 0.188 1.3 (0.9–1.9)
East Asian/Beijing 93 (0.41) 117 (0.52) 15 (0.07) 0.033 0.012 1.5 (1.1–2.1)
Bold entries indicate P-values o0.05.
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SNPs may be markers of non-synonymous structural variants of
MARCO that effects ability to bind ligands from Beijing lineage
strains, reducing phagocytosis and increasing susceptibility to TB.
Host–pathogen co-evolution in tuberculosis needs to be studied
on a larger scale with respect to patients and genes, coupled with
functional studies to determine the underlying mechanisms.
The role of MARCO in macrophage phagocytosis is important in
clearance of pathogens. Our results suggest that MARCO
polymorphisms may regulate phagocytosis of M. tuberculosis and
thus inﬂuence susceptibility to and severity of pulmonary
tuberculosis. The results also suggest that MARCO genotype and




Ex vivo isolation of PBMCs and MDMs. PBMCs were separated from
heparinized whole blood by Lymphoprep (Axis-Shield, Oslo, Norway)
gradient centrifugation according to the manufacturer’s protocol. From
20 ml of blood, we obtained ~ 1–1.5 × 107 PBMCs. To isolate monocytes by
adherence, PBMCs were plated in cell-culture-treated 48-well plates (Nunc,
Roskilde, Denmark) with 9x105 cells per well in media without serum,
containing RPMI-1640 (Sigma, Munich, Germany), 2 mM L-glutamine and
100 units of penicillin. Cells were incubated at 37 °C, 5% CO2 for 2 h and
the non-adhered cells were washed off gently two times by warm
phosphate-buffered saline (PBS) with 3% fetal calf serum (Sigma). Cells
were re-suspended in 0.4 ml complete media, containing RPMI-1640, 2 mM
L-glutamine, 100 units of penicillin, 10% fetal calf serum and 10 ng ml− 1
human mCSF (R&D Systems, Minneapolis, MN, USA), and incubated at 37 °
C, 5% CO2. To derive monocytes, adhered cells were incubated for 5–
7 days. Complete media was changed at day 4, and phagocytosis assay
was performed at day 7.
PBMC stimulation for MARCO mRNA and cytokine measurement. For
MARCO mRNA expression, PBMCs were plated in 24-well plates (106 cells per
well). Cells were subsequently stimulated with either whole-cell lysate of M.
tuberculosis H37Rv at 5 μg ml−1 (Colorado State University, USA), LPS at
100 ng ml−1 (Sigma-Aldrich, St Louis, MO, USA) or media. For cytokine
measurement, PBMCs were plated in 96-well plates (105 cells per well) and
then stimulated with either whole-cell lysate at 25 μg ml−1, TDM at 100 μg ml−1
(Enzo Life Sciences, Farmingdale, NY, USA), LPS 100 ng ml−1 or media. For
stimulation, TDM was coated on the plate and air-dried in the cabinet the day
before, while other ligands were added directly into media after cell plating.
For real-time quantitative PCR (RT-qPCR), after stimulation for 5 h, RNA
was extracted by Trizol according to the manufacturer’s protocol
(Invitrogen, Carlsbad, CA, USA), dissolved in RNase-free water and stored
at − 70 °C until use. Taqman real-time PCR was performed to measure the
expression level of MARCO gene using primers forward 5′-
GGGCTCACCTGGTGGTTATC-3′ and reverse 5′-TCGACAACCTGGTCTGACAGT-3′
(Sigma-Aldrich Pte Ltd, Singapore), and probe 5′-Cyan500-CTCCGGGTCCTG
GAGATGTATTTCCTCA-BHQ1-3′ (TIB MOLBIOL Syntheselabor GmbH, Berlin,
Germany). Samples were normalized to glyceraldehyde-3-phosphate
dehydrogenase and analyzed by using LightCycler 480 release 1.5.1.62
Relative Quantiﬁcation software (Roche, Ho Chi Minh City, Vietnam).
For cytokine measurement, after stimulation for 24 h, supernatants were
collected for cytokine measurement, including TNF-α, IL-1β and IL-10. Cytokine
levels were determined with a sandwich ELISA technique by the Luminex
multiplex bead array technology (Bio-Rad Laboratories, Inc., Hercules, CA, USA).
Preparation of beads for phagocytosis. The procedure of coating beads
was adopted from Yates et al.29 Carboxylate-modiﬁed silica particles
(25 mg or 500 μl of 3 μm; Kisker Biotech, Steinfurt, Germany) were washed
three times in 1 ml of PBS by vortexing and centrifugation at 2000 g for
1 min. Beads were incubated at room temperature in 25 mg ml− 1
cyanamide (Sigma-Aldrich), which works as a cross-linker, in PBS with
agitation for 15 min. Beads were washed twice in 1 ml of coupling buffer
(0.1 M borate buffer, pH 8.0) and then incubated in 0.5 ml coupling buffer
with 1.0 mg defatted bovine serum albumin (Sigma-Aldrich) and 0.1 mg
human IgG (Molecular Probes, Eugene, OR, USA) or 0.25 mg ligands (TDM
(Enzo Life Sciences) or β-glucan/whole glucan particles (Invivogen, San
Diego, CA, USA)) then dispersed for 12 h with agitation. The coated beads
were washed three times in 1 ml of quench buffer (250 mM glycine, Sigma-
Aldrich) to quench unreacted cyanamide. The beads were re-suspended in
1 ml coupling buffer with 10 μl of 5 mg ml− 1 Alexa Fluor 594 succidinimyl
ester (Molecular Probes) in dimethyl sulfoxide (DMSO, Sigma-Aldrich) and
agitated for 1 h. The beads were washed three times in 1 ml quench buffer,
re-suspended in 1 ml PBS with 0.02% sodium azide and stored at 4 °C.
Phagocytosis assays. At day 7, MDMs from healthy subjects or TB patients
were checked by microscope to ensure a monolayer with 80–90%
conﬂuence had been achieved. After removing media, new media was
added immediately with 200 μl per well in the 48-well plates. Stored beads
were washed three times in PBS, then 10 μl of beads coated with Alexa
Fluor 594 SE and IgG/ligand was added into each well with concentration
to achieve an average of 1–2 beads internalized per macrophage. Binding
and uptake of the beads was performed by incubating of macrophages
with a suspension of the beads at 37 °C, 5% CO2 for 10 min. Cells were
washed three times in PBS with 3% FBS to remove unbound beads,
harvested by scraping in cold PBS with 1% para-formaldehyde and
transferred into a tube for ﬂow cytometry analysis.
Phagocytosis of macrophages was determined by the percentage of
phagocytes that have internalized beads coated with Alexa Fluor 594 SE.
Samples were run using BD FACSCanto II and FACSDiva acquisition
software (Becton Dickinson, San Diego, CA, USA), and ﬂuorescence
intensity analyzed using FlowJo analysis software (BD Biosciences, San
Jose, CA, USA). Bead ingestion was conﬁrmed by the presence of bright
green ﬂuorescence in the proteolysis assay (Supplementary Figure S3). The
green ﬂuorescence indicated that almost all of the MDM-associated beads
were internalized following 10 min incubation.
Haplotype-tagging SNPs
We identiﬁed haplotype-tagging SNPs from the Han Chinese in Beijing
(CHB) population from the International HapMap Project (http://www.
hapmap.org) and obtained functional information of SNPs from UCSC
Genome Bioinformatics (http://genome.ucsc.edu/). We searched a region
on chromosome 2p14.2 encompassing MARCO and 10 kb upstream for
tagged SNPs using an r2 cutoff of 0.8 for linkage disequilibrium and a
minor allele frequency cut-off of 10%. Haploview 4.2 (Broad Institute of MIT
and Harvard, USA) was used to calculate r2 and D' for linkage
disequilibrium. Twelve haplotype-tagging SNPs including one SNP in the
promoter region (3 bp upstream) and one missense SNP (in exon 10) were
genotyped. SNPs in the MARCO gene were genotyped using the
GoldenGate genotyping assay (Illumina, San Diego, CA, USA).
Human subjects
For cellular studies, in addition to the TBM and PTB patients described
below, latent TB (LTB) subjects (N= 56) were recruited from healthy
Vietnamese volunteers working at Oxford University Clinical Research Unit
(OUCRU), Vietnam. They were diagnosed for LTB infection using T-SPOT.TB
test (Oxford Immunotec, Abingdon, UK). Another group of healthy
Vietnamese volunteers (N= 31) from OUCRU was enrolled in cellular
studies in which we genotyped SNPs on MARCO and examined
macrophage phagocytosis, mRNA expression and immune response.
The case–control genetics association study cases comprised of 900 HIV
negative adults with TB treated from 2008 to 2011 for PTB (N=450), and in
several clinical trials and observational studies from 2001 to 2013 for TBM
(N=450). PTB patients were recruited through the network of district TB
control units, and TBM patients were recruited from either Pham Ngoc
Thach Hospital for Tuberculosis and Lung Disease or the Hospital for Tropical
Diseases, in Ho Chi Minh City, Vietnam. PTB patients had acid fast bacilli in
sputum and TBM patients had clinical meningitis in addition to speciﬁc
clinical requirements that have been previously described.30 Population
controls were 450 newborn babies born at Hung Vuong Obstetric Hospital,
Ho Chi Minh City. Peripheral blood samples from TB patients or umbilical
cord blood from babies were collected. All samples came from unrelated
individuals who were ethnic Vietnamese Kinh.
Written informed consent was obtained from each volunteer. Protocols
were approved by human subjects review committees at the Hospital for
Tropical Diseases and Pham Ngoc Thach Hospital for TB and Lung Disease,
HCMC, Vietnam. Ethical approval was also granted by the Oxford Tropical
Research Ethics Committee (UK).
Case–control genetic association study and quality checking
Fourteen genotyped SNPs were tested for Hardy–Weinberg equilibrium
(HWE) in control subjects using a χ2-test. SNPs were excluded if they had
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45% missing genotype calls, a minor allele frequency of o10% or a HWE
P-value of o0.05.
Chest radiography
CXR were examined at the time of TB diagnosis, with reports provided by
clinicians from district TB control units. Abnormal features on a chest
radiograph were recorded comprising of nodules, inﬁltrates, consolidation,
cavities and miliary TB. To grade chest radiograph severity, the abnormal
features were assessed and classiﬁed as mild if abnormal features were
present in one lobe, intermediate if abnormal features were present in one
lung, and severe if abnormal features were present in both lungs.
Statistical analysis
Host genetic analysis was performed using a Chi-squared test with two
degrees of freedom in genotypic comparisons, or one in genotypic models
(that is, dominant, recessive or heterozygous advantage model). A
signiﬁcance threshold of Po0.05 was used. For multiple SNP comparisons,
Bonferroni correction was applied.
Comparisons across three clinical groups (PTB, TBM and controls) or
genotypes were performed by using one-way analysis of variance or two
groups by using Mann–Whitney U-test. Analyses were performed using
SPSS version 14.0, USA. mRNA, cytokine and phagocytosis graphs were
generated using GraphPad Prism version 6.04 for Windows (GraphPad
Software, La Jolla, CA, USA, www.graphpad.com).
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